Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

BACKGROUND: The aim of this study was to evaluate the prognostic potential of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) tumor tissue levels and examine the association between these biomarkers and classical prognostic factors in early node-negative...

Descripción completa

Detalles Bibliográficos
Autores principales: Jevrić, Marko, Matić, Ivana Z., Krivokuća, Ana, Đorđić Crnogorac, Marija, Besu, Irina, Damjanović, Ana, Branković-Magić, Mirjana, Milovanović, Zorka, Gavrilović, Dušica, Susnjar, Snezana, Kisić Tepavčević, Darija, Stanojković, Tatjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332605/
https://www.ncbi.nlm.nih.gov/pubmed/30646864
http://dx.doi.org/10.1186/s12885-018-5255-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332605/
https://www.ncbi.nlm.nih.gov/pubmed/30646864
http://dx.doi.org/10.1186/s12885-018-5255-z

Ejemplares similares